These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1314469)

  • 1. Antigenic N to H conversion of poliovirus by a monoclonal antibody at low ionic strength.
    Delaet I; Vrijsen R; Boeyé A
    Virology; 1992 May; 188(1):93-101. PubMed ID: 1314469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hit-and-run neutralization of poliovirus.
    Brioen P; Rombaut B; Boeyé A
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2495-9. PubMed ID: 2997379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies that disrupt poliovirus only at fever temperatures.
    Delaet I; Boeyé A
    J Virol; 1993 Sep; 67(9):5299-302. PubMed ID: 8394450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsid destabilization is required for antibody-mediated disruption of poliovirus.
    Delaet I; Boeyé A
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():581-7. PubMed ID: 8126454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
    Rombaut B; Vrijsen R; Boeyé A
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Schild GC
    Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A competition immunoprecipitation assay of unlabeled poliovirus antigens.
    Rombaut B; Jore J; Boeyé A
    J Virol Methods; 1994 Jun; 48(1):73-9. PubMed ID: 7962262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pH-dependent antigenic conversion of empty capsids of poliovirus studied with the aid of monoclonal antibodies to N and H antigen.
    Rombaut B; Vrijsen R; Brioen P; Boeyé A
    Virology; 1982 Oct; 122(1):215-8. PubMed ID: 6291235
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular basis of antigenic structures of poliovirus: implications for their evolution during morphogenesis.
    Wiegers K; Dernick R
    J Virol; 1992 Jul; 66(7):4597-600. PubMed ID: 1376371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody that neutralizes poliovirus by cross-linking virions.
    Thomas AA; Brioen P; Boeyé A
    J Virol; 1985 Apr; 54(1):7-13. PubMed ID: 2983121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in conformation of type 3 poliovirus antigenic sites on non-infectious empty particles and infectious virus.
    Ferguson M; Minor PD
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1271-4. PubMed ID: 1693661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
    Thibodeau L; Lacroix M; Lecomte J; Fauvel M
    Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
    Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
    J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.
    Icenogle J; Gilbert SF; Grieves J; Anderegg J; Rueckert R
    Virology; 1981 Nov; 115(1):211-5. PubMed ID: 6270899
    [No Abstract]   [Full Text] [Related]  

  • 16. A hybridoma cell line secreting antibody to poliovirus type 3 D-antigen: detection in virus harvest of two D-antigen populations.
    Ferguson M; Schild GC; Minor PD; Yates PJ; Spitz M
    J Gen Virol; 1981 Jun; 54(Pt 2):437-42. PubMed ID: 6270261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.
    Icenogle J; Shiwen H; Duke G; Gilbert S; Rueckert R; Anderegg J
    Virology; 1983 Jun; 127(2):412-25. PubMed ID: 6306918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
    Shyrobokov VP; Kostenko IH; Nikolaienko IV
    Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliovirus neutralization and the percentage law. Brief report.
    Brioen P; Boeyé A
    Arch Virol; 1985; 83(1-2):105-11. PubMed ID: 2982345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.